首页> 外文OA文献 >A Methodologic Approach for the Selection of Bio-Resorbable Polymers in the Development of Medical Devices: The Case of Poly(l-lactide-co-ε-caprolactone)
【2h】

A Methodologic Approach for the Selection of Bio-Resorbable Polymers in the Development of Medical Devices: The Case of Poly(l-lactide-co-ε-caprolactone)

机译:一种在医疗装置开发中选择生物可再吸收聚合物的方法方法:聚(L-丙交酯-co-ε-己内酯)的情况

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the last decades bioresorbable and biodegradable polymers have gained a very good reputation both in research and in industry thanks to their unique characteristics. They are able to ensure high performance and biocompatibility, at the same time avoiding post-healing surgical interventions for device removal. In the medical device industry, it is widely known that product formulation and manufacturing need to follow specific procedures in order to ensure both the proper mechanical properties and desired degradation profile. Moreover, the sterilization method is crucial and its impact on physical properties is generally underestimated. In this work we focused our attention on the effect of different terminal sterilization methods on two commercially available poly(l-lactide-co-ε-caprolactone) with equivalent chemical composition (70% PLA and 30% PCL) and relatively similar initial molecular weights, but different chain arrangements and crystallinity. Results obtained show that crystallinity plays a key role in helping preserve the narrow distribution of chains and, as a consequence, defined physical properties. These statements can be used as guidelines for a better choice of the most adequate biodegradable polymers in the production of resorbable medical devices.
机译:在过去的几十年中,由于其独特的特点,生物可见和可生物可获得的和可生物降解的聚合物在研究和工业中都获得了非常良好的声誉。他们能够确保高性能和生物相容性,同时避免了设备拆除后的修复手术干预。在医疗器械行业,它被广泛已知的是,产品配方和制造需要遵循,以便确保适当的机械性能和期望的降解轮廓两者的具体程序。此外,该灭菌方法是至关重要的,其对物理性能的影响通常低估。在这项工作中,我们侧重于不同终端灭菌方法的效果我们的注意力集中在两种可商购的聚(l-丙交酯 - 共 - ε - 己内酯)与当量的化学组成(70%PLA和30%PCL)和相对相似的初始分子量,但不同的链安排和结晶。结果表明采用结晶在帮助保护链的分布窄,并作为一个后果,定义物理性能关键的作用。这些陈述可用作更好地选择可再吸收的医疗装置中最适合的可生物降解聚合物的指导原则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号